These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1380608)

  • 81. Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats.
    Seymour AA; Norman JA; Asaad MM; Fennell SA; Swerdel JN; Little DK; Dorso CR
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):163-72. PubMed ID: 1696660
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
    Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
    Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats.
    Trapani AJ; Beil ME; Bruseo CW; Fink CA; Hoyer D; Savage P; Jeng AY
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():102S-106S. PubMed ID: 12193065
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.
    Fournié-Zaluski MC; Gonzalez W; Turcaud S; Pham I; Roques BP; Michel JB
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):4072-6. PubMed ID: 8171037
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man.
    Lainchbury JG; Nicholls MG; Espiner EA; Ikram H; Yandle TG; Richards AM
    Clin Sci (Lond); 1998 Nov; 95(5):547-55. PubMed ID: 9791040
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of neutral endopeptidase inhibition in the rat remnant kidney model.
    Jandeleit-Dahm K; Burrell LM; Kanazawa M; Casley D; Jackson B; Johnston CI
    Kidney Blood Press Res; 1998; 21(6):419-24. PubMed ID: 9933826
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cardiorenal effects of atrial natriuretic factor administration in congestive heart failure: natriuresis and diuresis without hemodynamic alterations.
    Firth BG; Perna R; Bellomo JF; Toto RD
    Am J Med Sci; 1989 Apr; 297(4):203-8. PubMed ID: 2565086
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Modulation of ANP-dependent effects of endothelin by inhibitors of neutral endopeptidase and cGMP phosphodiesterase.
    Valentin JP; Qiu C; Wiedemann E; Gardner DG; Humphreys MH
    J Pharmacol Exp Ther; 1995 May; 273(2):744-52. PubMed ID: 7752077
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Dicarboxylic acid dipeptide neutral endopeptidase inhibitors.
    Ksander GM; Ghai RD; deJesus R; Diefenbacher CG; Yuan A; Berry C; Sakane Y; Trapani A
    J Med Chem; 1995 May; 38(10):1689-700. PubMed ID: 7752193
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
    Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
    Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Maximizing the natriuretic peptide system in experimental heart failure: subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition.
    Chen HH; Lainchbury JG; Harty GJ; Burnett JC
    Circulation; 2002 Feb; 105(8):999-1003. PubMed ID: 11864932
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure.
    Aaser E; Gullestad L; Tølløfsrud S; Lundberg J; Hall C; Djøseland O; Kjekshus J; Forfang K
    Scand J Clin Lab Invest; 1997 Jul; 57(4):361-7. PubMed ID: 9249883
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure.
    Rademaker MT; Cameron VA; Charles CJ; Richards AM
    Circulation; 2005 Dec; 112(23):3624-32. PubMed ID: 16330704
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effects of neutral endopeptidase inhibition on the clearance of exogenously administered endothelin in Sprague-Dawley rats.
    Asaad MM; Dorso CR; Moreland SM
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):633-6. PubMed ID: 7681910
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Hemodynamic, renal, and hormonal effects of 8-Br-cyclic GMP in conscious dogs with and without congestive heart failure.
    Elsner D; Kromer EP; Riegger GA
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):241-7. PubMed ID: 2476597
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Inhibition of neutral endopeptidase (EC 3.4.24.11) leads to an atrial natriuretic factor-mediated natriuretic, diuretic and antihypertensive response in rodents.
    Shepperson NB; Barclay PL; Bennett JA; Samuels GM
    Clin Sci (Lond); 1991 Mar; 80(3):265-9. PubMed ID: 1850687
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The neutral endopeptidase inhibitor, SCH 34826, reduces left ventricular hypertrophy in spontaneously hypertensive rats.
    Monopoli A; Ongini E; Cigola E; Olivetti G
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):496-504. PubMed ID: 1279298
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors.
    Seymour AA; Mathers PD; Abboa-Offei BE; Asaad MM; Weber H
    J Cardiovasc Pharmacol; 1996 Sep; 28(3):397-401. PubMed ID: 8877586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.